Načítá se...
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
The COVID-19 pandemic caused by SARS-CoV-2 has emerged as a global catastrophe. The virus requires main protease for processing the viral polyproteins PP1A and PP1AB translated from the viral RNA. In search of a quick, safe and successful therapeutic agent; we screened various clinically approved dr...
Uloženo v:
| Vydáno v: | Int J Biol Macromol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier B.V.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444494/ https://ncbi.nlm.nih.gov/pubmed/32853604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijbiomac.2020.08.166 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|